First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic coronary arteries: 6-month clinical and angiographic follow-up from AVAIL study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples